• Users Online: 164
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
   Table of Contents - Current issue
Coverpage
July-September 2022
Volume 5 | Issue 3
Page Nos. 81-111

Online since Thursday, October 13, 2022

Accessed 3,786 times.

PDF access policy
Journal allows immediate open access to content in HTML + PDF
View as eBookView issue as eBook
Access StatisticsIssue statistics
RSS FeedRSS
Show all abstracts  Show selected abstracts  Export selected to  Add to my list
REVIEWS  

Research progress of drug resistance mechanisms to temozolomide in glioblastoma: A narrative review p. 81
Allen Lu
DOI:10.4103/glioma.glioma_24_22  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

Associations of O6-methylguanine-DNA methyltransferase promoter methylation status with age and 1p/19q codeletion status in isocitrate dehydrogenase mutation gliomas based on an Asian cohort: A narrative review p. 87
Xu Wang, Mingzhi Han
DOI:10.4103/glioma.glioma_25_22  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

Progress on TTFields combined with other therapies for glioblastoma treatment: A narrative review p. 90
Yong Cao, Haibin Wu, Bin Tang, Meihua Li, Yilv Wan, Jian Duan, Jiang Xu
DOI:10.4103/glioma.glioma_12_22  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta
CASE REPORTS Top

Brain metastases treated with CyberKnife and TomoTherapy: A report of three cases p. 99
Li Zhu, Ying Li, Xiangyu Kong, Anna Mu, Ye Zhang, Liping Chen, Xia Li
DOI:10.4103/glioma.glioma_23_22  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

WHO grade III diffuse astrocytic glioma in a 35-year-old male p. 107
Rong Du, Huandong Liu, Guoqing Yi, Huilin Cheng, Ping Liang
DOI:10.4103/glioma.glioma_26_22  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta
CORRIGENDUM Top

Corrigendum: Initial report of a clinical trial evaluating the safety and efficiency of neoadjuvant camrelizumab and apatinib in patients with recurrent high-grade gliomas: A prospective, phase II, single-arm study p. 110

DOI:10.4103/glioma.glioma_19_22  
[HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta